During the early 1990s, harm caused by illicit drugs, mainly heroin, in European Union (EU) Member States (MS) was one of the biggest concerns of European citizens. These years saw an increase in drug-induced deaths and other health-related consequences, as well as growing concerns regarding the...

EMCDDA-Europol joint report publications examine the detailed information provided by the EU Member States on individual new psychoactive substances. Information is collected from the Reitox network, the Europol national units and the national competent authorities of the European Medicines...

This second EMCDDA Programming Document (PD) covers the period 2018-20. Its timeframe falls within a transition period between the EMCDDA Strategy and work programme for 2016-18 and the new EMCDDA Strategy 2025, which was adopted by the Management Board in December 2016. Therefore, while the PD...

This second EMCDDA Programming Document (PD) covers the period 2018-20. Its timeframe falls within a transition period between the EMCDDA Strategy and work programme for 2016-18 and the new EMCDDA Strategy 2025, which was adopted by the Management Board in December 2016. Therefore, while the PD...

EMCDDA-Europol joint report publications examine the detailed information provided by the EU Member States on individual new psychoactive substances. Information is collected from the Reitox network, the Europol national units and the national competent authorities of the European Medicines...

With cannabis use and policy evolving internationally, drug-impaired driving has become an increasingly relevant policy issue. This briefing aims to provide those concerned with policy developments in the field of cannabis with a brief overview of current knowledge and the latest developments in...